A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy among Depressed Outpatients with Inadequate Response to Prior Antidepressant Therapy (ADAPT-A Study)

Fava, Maurizio, Mischoulon, David, Iosifescu, Dan, Witte, Janet, Pencina, Michael, Flynn, Martina, Harper, Linda, Levy, Michael, Rickels, Karl, Pollack, Mark·2012·Psychotherapy and Psychosomatics
DOI 10.1159/000332050

Cited by (140)

Items 101–140 of 140

  1. Permutation and Bootstrap Testing for the Sequential Parallel Comparison Design
    Rachel Kloss Silverman, Jason P. Fine, Richard C. Zink, Anastasia Ivanova · 2019 · Statistics in Biopharmaceutical Research
  2. Depression and Anxiety Disorders
    Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal · 2025 · Wiley eBooks
  3. A simple test for the treatment effect in clinical trials with a sequential parallel comparison design and negative binomial outcomes
    Gosuke Homma, Takashi Daimon · 2018 · Pharmaceutical Statistics
  4. A commentary on: statistical inference problems in sequential parallel comparison designs
    David Schoenfeld, Gheorghe D. Doros, Maurizio Fava M. D · 2019 · Journal of Biopharmaceutical Statistics
  5. Efficacy of aripiprazole as adjunctive therapy in major depressive disorder with somatic symptoms: A randomized, double-blind, placebo-controlled trial with clinical and electroencephalography evidence
    Hee Jin Kim, Doug Hyun Han, Kang Ta Choi, Hyunchan Hwang, Kyoung Joon Min, Sun Mi Kim · 2022 · Journal of Psychopharmacology
  6. Aripiprazole and Cariprazine for Bipolar Disorder?
    John R. Rossiter · 2022 · Open Journal of Medical Psychology
  7. Randomization-based analysis of covariance for inference in the sequential parallel comparison design
    Laura Elizabeth Wiener, Anastasia Ivanova, Siying Li, Rachel Kloss Silverman, Gary G. Koch · 2019 · Journal of Biopharmaceutical Statistics
  8. A Meta-Analysis of the Antidepressant Responses in Pivotal Trials on Esketamine Nasal Spray and Atypical Antipsychotics
    Lien Wang, Xiaowei Chen, Xiaojing Gu, Heidi De Smedt, Vanina Popova, Dong‐Jing Fu, Carla M. Canuso, Wayne Curtis Drevets, Guang Chen · 2023 · Neuropsychiatric Disease and Treatment
  9. Novel Study Designs for Clinical Trials in Mood Disorders
    Hong Jin Jeon, Maurizio Fava M. D · 2015 · Elsevier eBooks
  10. Adjunctive Ziprasidone in Major Depression and the Current Status of Adjunctive Atypical Antipsychotics
    James Craig Nelson · 2015 · American Journal of Psychiatry
  11. Estimating Causal Treatment Effects in the Sequential Parallel Comparison Design (SPCD)
    Yang Song, Maurizio Fava M. D, Chanmin Kim, Robert W. Yeh, Gheorghe D. Doros · 2025 · Statistics in Medicine
  12. Assessing treatment benefit in the presence of placebo response using the sequential parallel comparison design
    Xiaoyan Liu, Chanmin Kim, Zifei Han, Pilar Lim, Satrajit Roychoudhury, Maurizio Fava M. D, Gheorghe D. Doros · 2022 · Statistics in Medicine
  13. Pharmacological treatment of treatment-resistant depression: Towards evidence-based recommendations
    Stefan Jerotić, Maja Ivković · 2024 · Medicinska istrazivanja
  14. Neural Predictors of the Antidepressant Placebo Response
    Danielle N. Rette, Erin McDonald, Dan Vlad Iosifescu, Katherine Anne Collins · 2019 · Pharmaceuticals
  15. Sequential parallel comparison design with two coprimary endpoints
    Gosuke Homma, Takashi Daimon · 2019 · Pharmaceutical Statistics
  16. WITHDRAWN: Size Does Matter, But It Isn't Everything: The Challenge of Modest Treatment Effects in Chronic Pain Clinical Trials
    Shannon M. Smith, Maurizio Fava M. D, Mark P. Jensen, Omar B. Mbowe, Michael McDermott, Dennis C. Turk, Robert H. Dworkin · 2019 · Journal of Pain · Retracted
  17. Placebo Responses in Trials for Multiple Sclerosis
    Luana Gilio, Diego Centonze, Mario Stampanoni Bassi · 2025 · Neurologic Clinics
  18. Efficacy and safety of perospirone as adjunctive therapy in major depressive disorder patients with inadequate response to antidepressants: a randomized clinical trial
    Jin Liu, Sirui Gao, Bangshan Liu, Yumeng Ju, Mei Liao, Li Zhang, Zexuan Li, Qianqian Zhang, Xiaotian Zhao, Hao Tang et al. · 2025 · EClinicalMedicine
  19. Optimizing phase II clinical trials: novel trial designs
    David Schoenfeld · 2014 · Journal of the Peripheral Nervous System
  20. Using Placebo Response to Pain as a Predictor of Placebo Response in Mood Disorders
    Sara Costi, Katherine Anne Collins, Michael Davidson, Dan Vlad Iosifescu · 2016 · Current Behavioral Neuroscience Reports
  21. Notes on Use of the Odds Ratio under the Sequential Parallel Comparison Design with Binary Outcomes
    Kung‐Jong Lui · 2018 · Statistics in Biopharmaceutical Research
  22. Exact and asymptotic tests under the sequential parallel comparison design
    Kung‐Jong Lui · 2018 · Pharmaceutical Statistics
  23. Elucidating and unravelling the novel antidepressant mechanism of action for atypical antipsychotics: repurposing the atypical antipsychotics for more comprehensive therapeutic usage
    Olumuyiwa John Fasipe, Igbekele Ogunboye · 2024 · RPS Pharmacy and Pharmacology Reports
  24. Confidence intervals for overall response rate difference in the sequential parallel comparison design
    Guogen Shan, Xinlin Lu, Yahui Zhang, Samuel S. Wu · 2024 · Statistical Papers
  25. Inflammation and treatment resistance: Mechanisms and treatment implications
    Andrew H. Miller, Michael J. Lucido, Mandakh Bekhbat, Neeti D. Mehta, Xiangchuan Chen, Michael Tilghman Treadway, Jennifer C. Felger, Ebrahim Haroon · 2022 · Elsevier eBooks
  26. Resistant depression: criteria for determination, risk factors and therapeutic strategies
    Olena O. Khaustova · 2017 · Psychosomatic Medicine and General Practice
  27. A case study in identifying targeted patients population in major depressive disorder by enhanced enrichment design
    Peter G. Y. Zhang, Kevin Carroll, Mary Hobart, Carole Augustine, Gary G. Koch · 2017 · Pharmaceutical Statistics
  28. Depression and Anxiety Disorders
    2021 · Wiley eBooks
  29. Use of second generation antipsychotics for treatment-resistant major depressive disorder
    Rebecca Waite · 2014 · Mental Health Clinician
  30. Individualized Treatment of Depression
    2013 · WORLD SCIENTIFIC eBooks
  31. Low-Dose Combination of Aripiprazole for Treatment of Severe Depression with Cognitive Impairment: Case Report
    Leonardo Machado · 2016 · Juniper Online Journal of Case Studies
  32. Neurobiological Bases of the Use of Atypical Antipsychotics in Treatment-Resistant Major Depressive Disorder
    Julia Kirby · 2018 · uO Research (University of Ottawa)
  33. Addressing High Placebo Response in Neuroscience Clinical Trials
    Gheorghe D. Doros, Pilar Lim, Yuyin Liu · 2018 · ICSA book series in statistics
  34. Methods for the Sequential Parallel Comparison Design
    Rachel Kloss Silverman · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  35. Low-Dose Combination of Aripiprazole for Treatment of Severe Depression with Cognitive Impairment: Case Report
    Leonardo Dantas Machado · 2017 · Juniper Online Journal of Case Studies
  36. Clinical–ethical implications and applications
    Fabrizio Benedetti · 2020 · Oxford University Press eBooks
  37. Einsatz von Antipsychotika, Antikonvulsiva, Stimulantien, Benzodiazepinen und Hypnotika bei therapieresistenten Depressionen
    Stephan Köhler, Cora Schefft · 2022 · Springer eBooks
  38. Chapter 30. Aripiprazole and Brexpiprazole
    Nikolajs Birze, Chloe Yuan, Erica Cristina Garcia-Pittman · 2024 · American Psychiatric Association Publishing eBooks
  39. Adaptive Designs
    Jingjing Ye, Lei Nie · 2024 · ICSA book series in statistics
  40. Antipsychotic medications in affective disorders
    Gustavo Héctor Vázquez · 2025 · Elsevier eBooks